Table 3.

Multivariate Analysis of Risk of Adverse Events After TKA/THA in Patients With Behcet Versus Those Without Behcet

N = 1409	OR (95% CI)	P
Any adverse events	2.16 (1.59, 2.91)	<0.0001
Serious adverse events	1.78 (1.18, 2.64)	0.0051
Sepsis	3.03 (1.50, 6.01)	0.0016
Pulmonary embolism	2.93 (1.29, 6.45)	0.0083
Deep vein thrombosis	1.61 (0.82, 2.98)	0.1432
Surgical site infection	1.03 (0.43, 2.19)	0.9365
Minor adverse events	2.39 (1.73, 3.28)	<0.0001
Pneumonia	4.76 (2.55, 8.94)	<0.0001
Urinary tract infection	3.71 (2.46, 5.58)	<0.0001
Wound dehiscence	1.87 (0.83, 3.93)	0.1120
Acute kidney injury	1.81 (0.95, 3.34)	0.0619
Hematoma	1.64 (0.51, 4.50)	0.3629
Transfusion	0.98 (0.45, 1.92)	0.9540

THA = total hip arthroplasty, TKA = total knee arthroplasty

Bold entries represent statistically significant P values at P < 0.05.